Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

BACKGROUND: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New Approach riVaroxaban Inhibition of Factor Xa in a Global trial versus ASA to prevenT Embolism in Embolic St...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Stroke J
Main Authors: Hart, Robert G, Sharma, Mukul, Mundl, Hardi, Shoamanesh, Ashkan, Kasner, Scott E, Berkowitz, Scott D, Pare, Guillaume, Kirsch, Bodo, Pogue, Janice, Pater, Calin, Peters, Gary, Davalos, Antoni, Lang, Wilfried, Wang, Yongjun, Wang, Yilong, Cunha, Luis, Eckstein, Jens, Tatlisumak, Turgut, Shamalov, Nikolay, Mikulik, Robert, Lavados, Pablo, Hankey, Graeme J, Czlonkowska, Anna, Toni, Danilo, Ameriso, Sebastian F, Gagliardi, Rubens J, Amarenco, Pierre, Bereczki, Daniel, Uchiyama, Shinichiro, Lindgren, Arne, Endres, Matthias, Brouns, Raf, Yoon, Byung-Woo, Ntaios, George, Veltkamp, Roland, Muir, Keith W, Ozturk, Serefnur, Arauz, Antonio, Bornstein, Natan, Bryer, Alan, O’Donnell, Martin J, Weitz, Jeffrey, Peacock, Frank, Themeles, Ellison, Connolly, Stuart J
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2016
Fag:
Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301240/
https://ncbi.nlm.nih.gov/pubmed/31008276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987316663049
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker